On January 19, 2023, Andrew Jones advised NovaBay Pharmaceuticals, Inc. (the “Company”) of his decision to voluntarily resign from his position as the Company's Treasurer effective as of February 15, 2023. Mr. Jones did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Due to Mr. Jones' departure, the Board of Directors of the Company appointed Tommy Law, currently the Company's Controller, as the Company's Treasurer, effective February 16, 2023, until a permanent replacement can be found.

The Company expects to launch a search for a Treasurer immediately. Mr. Law, age 37, has served the Company since December 2019 in a variety of positions, most recently as the Corporate Controller since September 2022. As the Corporate Controller, Mr. Law was responsible for quarterly filings with the SEC, as well as managing the periodic financial close process.

Prior to serving as the Corporate Controller, Mr. Law served the Company as an Assistant Controller (April 2022 to September 2022), Accounting Manager (June 2020 to April 2022) and Senior Accountant (December 2019 to June 2020). Prior to joining the Company, Mr. Law was a Senior Accountant at KP LLC, a marketing solutions company, from January 2017 to December 2019. Previously, he served as Accounting Manager at Hitachi Solutions America Ltd., an information technology company, from 2012 to 2015.

Mr. Law received a B.S. in Business Administration, Accounting from the San Jose State University.